The Influence of Drug-Polymer Solubility on Laser-Induced In Situ Drug Amorphization Using Photothermal Plasmonic Nanoparticles
In this study, laser-induced in situ amorphization (i.e., amorphization inside the final dosage form) of the model drug celecoxib (CCX) with six different polymers was investigated. The drug-polymer combinations were studied with regard to the influence of (i) the physicochemical properties of the p...
Na minha lista:
Main Authors: | , , , , , , |
---|---|
Formato: | Livro |
Publicado em: |
MDPI AG,
2021-06-01T00:00:00Z.
|
Assuntos: | |
Acesso em linha: | Connect to this object online. |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_44615c36a38d4452ac95afc63d8664d0 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Nele-Johanna Hempel |e author |
700 | 1 | 0 | |a Padryk Merkl |e author |
700 | 1 | 0 | |a Matthias Manne Knopp |e author |
700 | 1 | 0 | |a Ragna Berthelsen |e author |
700 | 1 | 0 | |a Alexandra Teleki |e author |
700 | 1 | 0 | |a Georgios A. Sotiriou |e author |
700 | 1 | 0 | |a Korbinian Löbmann |e author |
245 | 0 | 0 | |a The Influence of Drug-Polymer Solubility on Laser-Induced In Situ Drug Amorphization Using Photothermal Plasmonic Nanoparticles |
260 | |b MDPI AG, |c 2021-06-01T00:00:00Z. | ||
500 | |a 10.3390/pharmaceutics13060917 | ||
500 | |a 1999-4923 | ||
520 | |a In this study, laser-induced in situ amorphization (i.e., amorphization inside the final dosage form) of the model drug celecoxib (CCX) with six different polymers was investigated. The drug-polymer combinations were studied with regard to the influence of (i) the physicochemical properties of the polymer, e.g., the glass transition temperature (<i>T</i><sub>g</sub>) and (ii) the drug-polymer solubility on the rate and degree of in situ drug amorphization. Compacts were prepared containing 30 wt% CCX, 69.25 wt% polymer, 0.5 wt% lubricant, and 0.25 wt% plasmonic nanoparticles (PNs) and exposed to near-infrared laser radiation. Upon exposure to laser radiation, the PNs generated heat, which allowed drug dissolution into the polymer at temperatures above its <i>T</i><sub>g</sub>, yielding an amorphous solid dispersion. It was found that in situ drug amorphization was possible for drug-polymer combinations, where the temperature reached during exposure to laser radiation was above the onset temperature for a dissolution process of the drug into the polymer, i.e., <i>T</i><sub>DStart</sub>. The findings of this study showed that the concept of laser-induced in situ drug amorphization is applicable to a range of polymers if the drug is soluble in the polymer and temperatures during the process are above <i>T</i><sub>DStart</sub>. | ||
546 | |a EN | ||
690 | |a oral drug delivery | ||
690 | |a in situ drug amorphization | ||
690 | |a polymers | ||
690 | |a amorphous solid dispersion | ||
690 | |a laser radiation | ||
690 | |a plasmonic nanoparticles | ||
690 | |a Pharmacy and materia medica | ||
690 | |a RS1-441 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Pharmaceutics, Vol 13, Iss 6, p 917 (2021) | |
787 | 0 | |n https://www.mdpi.com/1999-4923/13/6/917 | |
787 | 0 | |n https://doaj.org/toc/1999-4923 | |
856 | 4 | 1 | |u https://doaj.org/article/44615c36a38d4452ac95afc63d8664d0 |z Connect to this object online. |